|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
CA1288073C
(en)
|
1985-03-07 |
1991-08-27 |
Paul G. Ahlquist |
Rna transformation vector
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
US6750325B1
(en)
|
1989-12-21 |
2004-06-15 |
Celltech R&D Limited |
CD3 specific recombinant antibody
|
|
US5968509A
(en)
|
1990-10-05 |
1999-10-19 |
Btp International Limited |
Antibodies with binding affinity for the CD3 antigen
|
|
CA2103059C
(en)
|
1991-06-14 |
2005-03-22 |
Paul J. Carter |
Method for making humanized antibodies
|
|
GB9206422D0
(en)
|
1992-03-24 |
1992-05-06 |
Bolt Sarah L |
Antibody preparation
|
|
US7381803B1
(en)
|
1992-03-27 |
2008-06-03 |
Pdl Biopharma, Inc. |
Humanized antibodies against CD3
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
|
AU728657B2
(en)
|
1996-03-18 |
2001-01-18 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
|
DK0979281T3
(da)
|
1997-05-02 |
2005-11-21 |
Genentech Inc |
Fremgangsmåde til fremstilling af multispecifikke antistoffer med heteromultimere og fælles bestanddele
|
|
PT1642972E
(pt)
|
1999-01-07 |
2010-04-07 |
Zymogenetics Inc |
Utilizações terapêuticas de receptores solúveis br43x2
|
|
WO2001012812A2
(en)
|
1999-08-17 |
2001-02-22 |
Biogen, Inc. |
Baff receptor (bcma), an immunoregulatory agent
|
|
AU6232899A
(en)
|
1999-10-06 |
2001-05-10 |
Campina Melkunie B.V. |
Use of transforming growth factor beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa
|
|
UA74798C2
(uk)
|
1999-10-06 |
2006-02-15 |
Байоджен Айдек Ма Інк. |
Спосіб лікування раку у ссавця за допомогою поліпептиду, що протидіє взаємодії april з його рецепторами
|
|
PT2857516T
(pt)
|
2000-04-11 |
2017-08-28 |
Genentech Inc |
Anticorpos multivalentes e utilizações dos mesmos
|
|
WO2001087977A2
(en)
|
2000-05-12 |
2001-11-22 |
Amgen Inc. |
Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
|
|
EP2301971A1
(en)
|
2001-02-20 |
2011-03-30 |
ZymoGenetics, L.L.C. |
Antibodies that bind both BCMA and TACI
|
|
CN1195779C
(zh)
|
2001-05-24 |
2005-04-06 |
中国科学院遗传与发育生物学研究所 |
抗人卵巢癌抗人cd3双特异性抗体
|
|
GB0115256D0
(en)
|
2001-06-21 |
2001-08-15 |
Babraham Inst |
Mouse light chain locus
|
|
AU2003287345A1
(en)
|
2002-10-31 |
2004-06-07 |
Genentech, Inc. |
Methods and compositions for increasing antibody production
|
|
US7575893B2
(en)
|
2003-01-23 |
2009-08-18 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
|
AU2004242847B2
(en)
|
2003-05-31 |
2011-06-09 |
Amgen Research (Munich) Gmbh |
Pharmaceutical composition comprising a bispecific antibody for EpCAM
|
|
RU2005141512A
(ru)
|
2003-05-31 |
2007-07-20 |
Микромет Аг (De) |
Фармацевтические композиции, включающие биспецифические анти-cd3, анти-cd19 конструкции антител для лечения расстройств, связанных с b-клетками
|
|
EP2292664B1
(en)
|
2003-10-16 |
2016-11-23 |
Amgen Research (Munich) GmbH |
Multispecific deimmunized CD3-binders
|
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
|
WO2005118635A2
(en)
|
2004-06-03 |
2005-12-15 |
Novimmune S.A. |
Anti-cd3 antibodies and methods of use thereof
|
|
LT2311874T
(lt)
|
2004-07-22 |
2017-11-27 |
Erasmus University Medical Center Rotterdam |
Rišančiosios molekulės
|
|
US8207303B2
(en)
|
2005-02-18 |
2012-06-26 |
Medarex, Inc. |
Monoclonal antibodies against CD30 lacking in fucosyl residues
|
|
US20160355591A1
(en)
|
2011-05-02 |
2016-12-08 |
Immunomedics, Inc. |
Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
|
|
JP2008543839A
(ja)
|
2005-06-14 |
2008-12-04 |
アムジェン インコーポレーテッド |
自己緩衝タンパク質製剤
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
WO2007033230A2
(en)
|
2005-09-12 |
2007-03-22 |
Novimmune S.A. |
Anti-cd3 antibody formulations
|
|
EP3770174A1
(en)
|
2005-10-11 |
2021-01-27 |
Amgen Research (Munich) GmbH |
Compositions comprising cross-species-specific antibodies and uses thereof
|
|
ES2618543T3
(es)
|
2005-11-23 |
2017-06-21 |
Genentech, Inc. |
Métodos y composiciones relacionados con ensayos de linfocitos B
|
|
WO2007066109A1
(en)
|
2005-12-06 |
2007-06-14 |
Domantis Limited |
Bispecific ligands with binding specificity to cell surface targets and methods of use therefor
|
|
WO2007117600A2
(en)
|
2006-04-07 |
2007-10-18 |
Macrogenics, Inc. |
Combination therapy for treating autoimmune diseases
|
|
US7862813B2
(en)
|
2006-07-29 |
2011-01-04 |
Bjork Jr Robert Lamar |
Bi-specific monoclonal antibody (specific for both CD3 and CD11b) therapeutic drug
|
|
WO2008119566A2
(en)
|
2007-04-03 |
2008-10-09 |
Micromet Ag |
Cross-species-specific bispecific binders
|
|
PT2520590T
(pt)
|
2007-04-03 |
2018-11-14 |
Amgen Res Munich Gmbh |
Domínio de ligação específico de espécies cruzadas
|
|
RU2561457C2
(ru)
|
2007-04-03 |
2015-08-27 |
Эмджен Рисерч (Мьюник) Гмбх |
Cd3-эпсилон-связывающий домен с межвидовой специфичностью
|
|
EP2336329B8
(en)
|
2007-06-01 |
2012-11-21 |
Omt, Inc. |
Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenis human idiotype antibodies
|
|
CN101874042B9
(zh)
|
2007-09-26 |
2019-01-01 |
中外制药株式会社 |
利用cdr的氨基酸取代来改变抗体等电点的方法
|
|
CN101918453A
(zh)
|
2007-10-26 |
2010-12-15 |
俄克拉荷马医学研究基金会 |
针对活化蛋白c的单克隆抗体
|
|
WO2009132058A2
(en)
|
2008-04-25 |
2009-10-29 |
Zymogenetics, Inc. |
Levels of bcma protein expression on b cells and use in diagnostic methods
|
|
US20100122358A1
(en)
|
2008-06-06 |
2010-05-13 |
Crescendo Biologics Limited |
H-Chain-only antibodies
|
|
UY31987A
(es)
*
|
2008-07-17 |
2010-02-26 |
Novartis Ag |
Anticuerpos monoclonales o proteinas funcionales antagonistas de baffr , con actividad consumidora de las celulas -b in vivo, composiciones, preparaciones y aplicaciones.
|
|
DK2356153T3
(en)
|
2008-10-01 |
2016-07-04 |
Amgen Res Munich Gmbh |
Bispecific single CHAIN PSMAXCD3 ANTIBODY THAT ARE SPECIFICALLY TO ALL SPECIES
|
|
CA2738566C
(en)
|
2008-10-01 |
2024-04-30 |
Micromet Ag |
Bispecific single chain antibodies with specificity for high molecular weight target antigens
|
|
EP2352765B1
(en)
|
2008-10-01 |
2018-01-03 |
Amgen Research (Munich) GmbH |
Cross-species-specific single domain bispecific single chain antibody
|
|
BRPI0919840B1
(pt)
|
2008-10-01 |
2023-02-28 |
Amgen Research (Munich) Gmbh |
Molécula de anticorpo de cadeia única biespecífica, seu uso, e composição farmacêutica que a compreende
|
|
NZ594985A
(en)
*
|
2009-03-10 |
2013-07-26 |
Biogen Idec Inc |
Anti-bcma (b-cell maturation antigen, cd269, tnfrsf17) antibodies
|
|
GB0905023D0
(en)
|
2009-03-24 |
2009-05-06 |
Univ Erasmus Medical Ct |
Binding molecules
|
|
US9345661B2
(en)
|
2009-07-31 |
2016-05-24 |
Genentech, Inc. |
Subcutaneous anti-HER2 antibody formulations and uses thereof
|
|
ES2603559T5
(es)
|
2010-02-08 |
2021-02-22 |
Regeneron Pharma |
Cadena ligera común de ratón
|
|
TWI653333B
(zh)
|
2010-04-01 |
2019-03-11 |
安進研究（慕尼黑）有限責任公司 |
跨物種專一性之ＰＳＭＡｘＣＤ３雙專一性單鏈抗體
|
|
JP2014500879A
(ja)
|
2010-11-16 |
2014-01-16 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｂｃｍａ発現に相関性を有する疾患を治療する因子及び方法
|
|
WO2012122512A1
(en)
|
2011-03-10 |
2012-09-13 |
Hco Antibody, Inc. |
Recombinant production of mixtures of single chain antibodies
|
|
US20130101599A1
(en)
*
|
2011-04-21 |
2013-04-25 |
Boehringer Ingelheim International Gmbh |
Bcma-based stratification and therapy for multiple myeloma patients
|
|
UA112434C2
(uk)
|
2011-05-27 |
2016-09-12 |
Ґлаксо Ґруп Лімітед |
Антигензв'язувальний білок, який специфічно зв'язується з всма
|
|
PE20141045A1
(es)
|
2011-05-27 |
2014-09-10 |
Glaxo Group Ltd |
Proteinas de union a bcma (cd269/tnfrsf17)
|
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對ｂｃｍａ之e3以及ｃｄ３的結合分子
|
|
KR102086874B1
(ko)
|
2012-04-11 |
2020-03-10 |
더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
B-세포 성숙 항원을 표적화하는 키메라 항원 수용체
|
|
CA2870545A1
(en)
|
2012-04-20 |
2013-10-24 |
Emergent Product Development Seattle, Llc |
Cd3 binding polypeptides
|
|
US20150203591A1
(en)
|
2012-08-02 |
2015-07-23 |
Regeneron Pharmaceuticals, Inc. |
Mutivalent antigen-binding proteins
|
|
JOP20200236A1
(ar)
|
2012-09-21 |
2017-06-16 |
Regeneron Pharma |
الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
|
|
US10002206B2
(en)
|
2012-10-26 |
2018-06-19 |
Saturn Licensing Llc |
Information processing device and information processing method
|
|
JP6694712B2
(ja)
|
2012-11-01 |
2020-05-20 |
マックス−デルブルック−セントラム フアー モレキュラーレ メデジン |
Ｃｄ２６９（ｂｃｍａ）に対する抗体
|
|
TW201425336A
(zh)
|
2012-12-07 |
2014-07-01 |
Amgen Inc |
Ｂｃｍａ抗原結合蛋白質
|
|
EP2931030B2
(en)
|
2012-12-14 |
2024-01-17 |
OmniAb, Inc. |
Polynucleotides encoding rodent antibodies with human idiotypes and animals comprising same
|
|
JPWO2014112144A1
(ja)
|
2013-01-15 |
2017-01-19 |
国立大学法人 熊本大学 |
染色体セントロメア由来のサテライトノンコーディングｒｎａを標的とした核酸抗癌剤、及び該抗癌剤を用いる方法
|
|
EP2762497A1
(en)
|
2013-02-05 |
2014-08-06 |
EngMab AG |
Bispecific antibodies against CD3epsilon and BCMA
|
|
US10077315B2
(en)
|
2013-02-05 |
2018-09-18 |
Engmab Sàrl |
Bispecific antibodies against CD3 and BCMA
|
|
JP2016528167A
(ja)
|
2013-04-29 |
2016-09-15 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ヒトＦｃＲｎ結合改変抗体及び使用方法
|
|
CA2927099A1
(en)
|
2013-10-31 |
2015-05-07 |
Sanofi |
Specific anti-cd38 antibodies for treating human cancers
|
|
MY176522A
(en)
|
2013-11-04 |
2020-08-13 |
Ichnos Sciences SA |
Production of t cell retargeting hetero-dimeric immunoglobulins
|
|
WO2015095412A1
(en)
|
2013-12-19 |
2015-06-25 |
Zhong Wang |
Bispecific antibody with two single-domain antigen-binding fragments
|
|
EP3105252B1
(en)
|
2014-02-12 |
2019-07-24 |
Michael Uhlin |
Bispecific antibodies for use in stem cell transplantation
|
|
WO2015142661A1
(en)
|
2014-03-15 |
2015-09-24 |
Novartis Ag |
Regulatable chimeric antigen receptor
|
|
TWI701042B
(zh)
|
2014-03-19 |
2020-08-11 |
美商再生元醫藥公司 |
用於腫瘤治療之方法及抗體組成物
|
|
EP3122781B1
(en)
|
2014-03-28 |
2020-01-01 |
Xencor, Inc. |
Bispecific antibodies that bind to cd38 and cd3
|
|
CA2951234C
(en)
|
2014-06-06 |
2022-05-31 |
Bristol-Myers Squibb Company |
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof
|
|
JP7054622B2
(ja)
|
2014-07-21 |
2022-04-14 |
ノバルティス アーゲー |
ヒト化抗ｂｃｍａキメラ抗原受容体を使用した癌の処置
|
|
SG10201900455YA
(en)
|
2014-07-24 |
2019-02-27 |
Bluebird Bio Inc |
Bcma chimeric antigen receptors
|
|
CA2955947A1
(en)
|
2014-07-25 |
2016-01-28 |
Cytomx Therapeutics, Inc. |
Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same
|
|
ES2688035T3
(es)
|
2014-08-29 |
2018-10-30 |
Gemoab Monoclonals Gmbh |
Receptor de antígeno universal que expresa células inmunes para direccionamiento de antígenos múltiples diversos, procedimiento para fabricación del mismo y utilización del mismo para tratamiento de cáncer, infecciones y enfermedades autoinmunes
|
|
TWI706960B
(zh)
|
2014-09-26 |
2020-10-11 |
美商宏觀基因股份有限公司 |
能夠結合cd19和cd3的雙特異性雙抗體及其用途
|
|
CN105457024B
(zh)
|
2014-10-13 |
2021-03-16 |
李小彦 |
抗butyrophilin-3人源化抗体及其使用
|
|
ES2701061T5
(es)
|
2014-10-22 |
2022-05-09 |
Crescendo Biologics Ltd |
Ratones transgénicos
|
|
EP3023437A1
(en)
|
2014-11-20 |
2016-05-25 |
EngMab AG |
Bispecific antibodies against CD3epsilon and BCMA
|
|
DK3221357T3
(da)
|
2014-11-20 |
2020-08-10 |
Hoffmann La Roche |
Fælles letkæder og fremgangsmåder til anvendelse
|
|
WO2016094304A2
(en)
|
2014-12-12 |
2016-06-16 |
Bluebird Bio, Inc. |
Bcma chimeric antigen receptors
|
|
GB201500461D0
(en)
|
2015-01-12 |
2015-02-25 |
Cresendo Biolog Ltd |
Therapeutic molecules
|
|
MA42136A
(fr)
|
2015-05-20 |
2018-03-28 |
Janssen Biotech Inc |
Anticorps anti-cd38 pour le traitement de l'amyloïdose à chaînes légères et d'autres tumeurs malignes hématologiques positives à cd38
|
|
CN105384825B
(zh)
|
2015-08-11 |
2018-06-01 |
南京传奇生物科技有限公司 |
一种基于单域抗体的双特异性嵌合抗原受体及其应用
|
|
IL298041B2
(en)
|
2015-08-17 |
2025-10-01 |
Janssen Pharmaceutica Nv |
Anti-BCMA antibodies, bispecific antigen-binding molecules that bind BCMA and CD3, and uses thereof
|
|
AU2016352676A1
(en)
|
2015-11-10 |
2018-05-31 |
University Medical Center Hamburg - Eppendorf |
ANTIGEN-binding polypeptides directed against CD38
|
|
CA3029209A1
(en)
|
2016-06-21 |
2017-12-28 |
Teneobio, Inc. |
Cd3 binding antibodies
|
|
WO2018039180A1
(en)
|
2016-08-24 |
2018-03-01 |
Teneobio, Inc. |
Transgenic non-human animals producing modified heavy chain-only antibodies
|
|
UA126384C2
(uk)
|
2016-09-14 |
2022-09-28 |
Тенеобіо, Інк. |
Антитіло, яке зв'язує cd3
|
|
NZ795790A
(en)
|
2016-12-21 |
2025-11-28 |
Teneobio Inc |
Anti-BCMA heavy chain-only antibodies
|
|
WO2018224660A1
(en)
|
2017-06-09 |
2018-12-13 |
Armin Ehninger |
Targeting modules for universal chimeric antigen receptor expressing immune cells and use in the treatment of cancer infections and autoimmune disorders
|
|
CA3065951A1
(en)
|
2017-06-20 |
2018-12-27 |
Teneoone, Inc. |
Anti-bcma heavy chain-only antibodies
|
|
US11970540B2
(en)
|
2017-06-20 |
2024-04-30 |
Teneobio, Inc. |
Anti-BCMA heavy chain-only antibodies
|
|
WO2019000223A1
(en)
|
2017-06-27 |
2019-01-03 |
Nanjing Legend Biotech Co., Ltd. |
ENABLERS OF IMMUNE EFFECTOR CELLS OF CHIMERIC ANTIBODIES AND METHODS OF USE THEREOF
|
|
AU2018291128B2
(en)
|
2017-06-30 |
2024-10-10 |
Teneobio, Inc. |
Anti-B-cell maturation antigen chimeric antigen receptors with human domains
|
|
US11186649B2
(en)
|
2017-10-10 |
2021-11-30 |
Sanofi |
Anti-CD38 antibodies and methods of use
|
|
AU2018395273A1
(en)
|
2017-12-27 |
2020-08-13 |
Teneobio, Inc. |
CD3-delta/epsilon heterodimer specific antibodies
|
|
AU2019275284A1
(en)
|
2018-05-24 |
2021-01-14 |
Ayala Pharmaceuticals Inc. |
Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and immunotherapeutics and methods of use thereof
|
|
BR112020024074A2
(pt)
|
2018-07-20 |
2021-02-17 |
Teneobio, Inc. |
anticorpos de cadeia pesada com ligação a cd19
|
|
KR20210149076A
(ko)
|
2019-04-05 |
2021-12-08 |
테네오바이오, 인코포레이티드 |
Psma에 결합하는 중쇄 항체
|
|
CR20210622A
(es)
|
2019-06-14 |
2022-06-27 |
Teneobio Inc |
Anticuerpos multiespecíficos de cadena pesada que se unen a cd22 y cd3
|
|
JP7625007B2
(ja)
|
2020-04-29 |
2025-01-31 |
テネオバイオ， インコーポレイテッド |
重鎖定常領域が修飾された多重特異性重鎖抗体
|